Type / Class
Equity / Ordinary Shares, par value $0.000174 per share
Shares outstanding
55,803,824
Total 13F shares
217,709
Share change
-1,753,749
Total reported value
$282,000
Price per share
$1.67
Number of holders
5
Value change
-$1,721,326
Number of buys
3
Number of sells
12

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
13%
6,991,003
$6,082,000 30 Jun 2022
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
3%
1,677,519
$1,459,000 30 Jun 2022
13F
BlackRock Finance, Inc.
13F
Company
2.6%
1,434,960
$1,249,000 30 Jun 2022
13F
Kynam Capital Management, LP
13F
Company
1.3%
739,649
$643,000 30 Jun 2022
13F
JANUS HENDERSON GROUP PLC
13F
Company
1.3%
720,000
$637,000 30 Jun 2022
13F
Ikarian Capital, LLC
13F
Company
1.2%
677,859
$591,000 30 Jun 2022
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
1.2%
651,506
$567,000 30 Jun 2022
13F
Sio Capital Management, LLC
13F
Company
1.1%
597,678
$520,000 30 Jun 2022
13F
CITADEL ADVISORS LLC
13F
Company
0.73%
409,659
$357,000 30 Jun 2022
13F
CITIGROUP INC
13F
Company
0.67%
375,367
$327,000 30 Jun 2022
13F
DAFNA Capital Management LLC
13F
Company
0.45%
250,000
$218,000 30 Jun 2022
13F
UBS Group AG
13F
Company
0.19%
105,185
$91,000 30 Jun 2022
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.14%
77,851
$68,000 30 Jun 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.12%
66,900
$58,000 30 Jun 2022
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.05%
28,016
$24,000 30 Jun 2022
13F
Chicago Partners Investment Group LLC
13F
Company
0.04%
20,651
$17,000 30 Jun 2022
13F
CSS LLC/IL
13F
Company
0.04%
20,000
$17,000 30 Jun 2022
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.03%
19,453
$17,000 30 Jun 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.03%
19,032
$16,000 30 Jun 2022
13F
Vident Investment Advisory, LLC
13F
Company
0.03%
18,062
$16,000 30 Jun 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0.03%
16,825
$15,000 30 Jun 2022
13F
Virtu Financial LLC
13F
Company
0.03%
16,658
$14,000 30 Jun 2022
13F
D. E. Shaw & Co., Inc.
13F
Company
0.02%
13,750
$12,000 30 Jun 2022
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.02%
13,110
$11,000 30 Jun 2022
13F
MORGAN STANLEY
13F
Company
0.01%
7,780
$7,000 30 Jun 2022
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,000
$1,000 30 Jun 2022
13F

Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q3 2022

As of 30 Sep 2022, Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by 5 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 217,709 shares. The largest 5 holders included CITIGROUP INC, ROCKY MOUNTAIN ADVISERS, LLC, SIMPLEX TRADING, LLC, UBS Group AG, and China Universal Asset Management Co., Ltd.. This page lists 5 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2022 vs Q2 2022 Across Filers

Q2 2022 holders
26
Q3 2022 holders
5
Holder diff
-21
Investor Q2 2022 Shares Q3 2022 Shares Share Diff Share Chg % Q2 2022 Value $ Q3 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.